ew biomarker HRG (Histidine-Rich Glycoprotein) that enables early diagnosis and severity assessment of sepsis
Not Applicable
- Conditions
- SepsisD046650
- Registration Number
- JPRN-jRCT1061220024
- Lead Sponsor
- Morimatsu Hiroshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
1 Inpatients who visited the emergency outpatient department of Okayama University Hospital or a joint research institute between March 31, 2023 after the approval of the Institutional Review Board and met two or more qSOFA criteria
2 Patients who can voluntarily obtain consent to participate in the study in writing from the person or his / her surrogate
Exclusion Criteria
1 Under 18 years old
2 Pregnant woman
3 Patients after resuscitation with cardiopulmonary arrest
4 Patients transferred from another hospital
5 Patients who are considered inappropriate for study for other reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical performance (sensitivity, specificity) of differential diagnosis of sepsis by HRG
- Secondary Outcome Measures
Name Time Method 1 Clinical performance (concordance) of differential diagnosis of sepsis by HRG<br>2 Relationship between HRG and prognosis